Cargando…
Albumin-derived perfluorocarbon-based artificial oxygen carriers can avoid hypoxic tissue damage in massive hemodilution
Artificial blood for clinical use is not yet available therefore, we previously developed artificial oxygen carriers (capsules) and showed their functionality in vitro and biocompatibility in vivo. Herein, we assessed the functionality of the capsules in vivo in a normovolemic hemodilution rat-model...
Autores principales: | Wrobeln, Anna, Jägers, Johannes, Quinting, Theresa, Schreiber, Timm, Kirsch, Michael, Fandrey, Joachim, Ferenz, Katja B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371727/ https://www.ncbi.nlm.nih.gov/pubmed/32686717 http://dx.doi.org/10.1038/s41598-020-68701-z |
Ejemplares similares
-
Perfluorocarbon-based oxygen carriers: from physics to physiology
por: Jägers, Johannes, et al.
Publicado: (2020) -
Deciphering
the Emulsification Process to Create an
Albumin-Perfluorocarbon-(o/w) Nanoemulsion with High Shelf Life and
Bioresistivity
por: Jaegers, Johannes, et al.
Publicado: (2022) -
Hypoxia-inducible factor 1α is Essential for Macrophage-mediated Erythroblast Proliferation in Acute Friend Retrovirus Infection
por: Schreiber, Timm, et al.
Publicado: (2017) -
Hypoxia-inducible factor-2α is crucial for proper brain development
por: Kleszka, Kira, et al.
Publicado: (2020) -
Myoglobin Protects Breast Cancer Cells Due to Its ROS and NO Scavenging Properties
por: Quinting, Theresa, et al.
Publicado: (2021)